EndoTODAY | EndoATLAS | Outpatient Clinic
Parasite | Esophagus | Stomach | Cancer | ESD
Home | Guide | Author | Search | Blog | Links
[Á¦20ȸ »ï¼º¼¿ïº´¿ø ³»°ú ¿¬¼ö°Á - 20³âÀÇ º¯È¿Í ³»°úÇÐÀÇ ¹ßÀü]
1. °©»ó¼±¾ÏÀÇ Á¶±â¹ß°ß°ú ¼ö¼ú¿¡ °üÇÑ ³í¶õ - ³»ºÐºñ´ë»ç³»°ú Á¤ÀçÈÆ
2010³â °©»ó¼±ÇÐȸ °¡À̵å¶óÀÎÀº '0.5cm º¸´Ù Å« °æ¿ì¿¡¸¸ FNAC¸¦ ½ÃÇàÇÏ´Â °ÍÀ» ¿ì¼±ÀûÀ¸·Î °í·ÁÇÑ´Ù'°í µÇ¾îÀÖ½À´Ï´Ù. ¿ì¸®³ª¶ó¿¡¼´Â 2010³â´ë ÃÊ¹Ý ¸Å³â 4¸¸¸í Á¤µµ ¼ö¼úÇÏ¿´°í 20%°¡ 0.5cm ÀÌÇÏ¿´½À´Ï´Ù.
2015³â ATA¿¡¼ ȹ±âÀûÀÎ ±Ç°í¾ÈÀ» ³Â½À´Ï´Ù (¸µÅ©). °á·ÐÀº (ÀϺΠ¿¹¿Ü´Â ÀÖÀ¸³ª) 1cm ÀÌÇÏ´Â ÂÁö ¸»ÀÚ´Â °ÍÀÔ´Ï´Ù. ¹Ì±¹¿¡¼µµ ¿Ü°úÀÇ»çµé°ú ¸¹Àº ³»°úÀÇ»çµéÀº ¹Ý´ëÇϰí ÀÖ½À´Ï´Ù. Áøº¸ÀûÀÎ ³»°úÀÇ»çµéÀÌ ÁöÁöÇÏ´Â ¾ÈÀÔ´Ï´Ù.
ÇöÀç 0.5-1cm ¾ÏÀ» °æ°ú°üÂûÇÏ´Â º´¿øÀº Àü¼¼°è¿¡ µÎ º´¿ø »ÓÀÔ´Ï´Ù. Kobe Kuma hospital, Tokyo Cancer Institute hospitalÀÔ´Ï´Ù.
0.5-1cm ¹Ì¼¼À¯µÎ¾ÏÀº ÀÏ´Ü ¼ö¼úÀ» ±ÇÇϰí 60 ȤÀº 70¼¼ À̻󿡼´Â °üÂûÀ» ÇÕ´Ï´Ù. ¹®Á¦´Â Àϼ± ÇöÀå¿¡¼´Â "ÀÇ»çµéÀÌ °üÂûÀ» ±ÇÇÏ´Â °í·ÉÀÚ´Â ¼ö¼úÀ» ¿øÇϰí, ÀÇ»çµéÀÌ ¼ö¼úÀ» ±ÇÇÏ´Â ÀþÀº ºÐÀº ¼ö¼úÀ» ¿øÇÏÁö ¾Ê´Â °æ¿ì°¡ ¸¹´Ù"´Â °ÍÀÔ´Ï´Ù. Á¤ÀçÈÆ ±³¼ö´ÔÀº ¾Æ·¡¿Í °°Àº °á·Ð ½½¶óÀ̵带 º¸¿© Áּ̽À´Ï´Ù.
Á¤ÀçÈÆ ±³¼ö´ÔÀÇ °á·Ð (¼ö¼ú°ú °üÂû) | |
°©»ó¼± Á¾¾ç <= 0.5 cm | - ÁÖÀ§·Î ÁøÇàµÈ Áõ°Å°¡ ÀÖÁö ¾Ê´Â ÇÑ ¼¼Æ÷°Ë»ç¸¦ ÇÏÁö ¾Ê´Â´Ù. - ÃÊÀ½ÆÄ»ó ¾Ç¼ºÀÌ ÀÇ½ÉµÇ¸é ±ä °£°ÝÀ¸·Î ÃÊÀ½ÆÄ¸¦ ÀÌ¿ëÇÑ °üÂûÀ» ÇÑ´Ù. |
°©»ó¼± ¹Ì¼¼À¯µÎ¾Ï 0.5-1.0 cm | - ¼ö¼ú (¿±ÀýÁ¦¼ú µµ´Â ÀüÀýÁ¦¼ú) vs. °üÂû (60¼¼ ÀÌ»óÀÌ ÁÁÀº ´ë»ó) - ÀþÀº ¿¬·ÉÃþÀÇ °æ¿ì ¾ðÁ¦±îÁö °üÂûÇÒ °ÍÀΰ¡? |
°©»ó¼± À¯µÎ¾Ï >=1.0 cm | - °©»ó¼±ÀüÀýÁ¦¼úÀÌ ¿øÄ¢ - °©»ó¼±¿¡ ±¹ÇÑµÈ °æ¿ì ¿±ÀýÁ¦¼úµµ °¡´É |
[ÀÌÁØÇà Àǰß]
ÀÏ´Ü '¹ß°ßµÈ °©»ó¼± °áÀý'¿¡ ´ëÇÑ Á¢±Ù¹ý Ãø¸é¿¡¼ ¸Å¿ì À¯ÀÍÇÑ °ÀÇ¿´½À´Ï´Ù. ´Ù¸¸ °ËÁø ÃÊÀ½ÆÄ°Ë»ç°¡ ÇÊ¿äÇÑÁö Åä·ÐÀÌ ¾ø¾ú´Ù´Â Á¡¿¡¼ ´Ù¼Ò ¾Æ½¬¾ú½À´Ï´Ù. ¹®Á¦ÀÇ ÇÙ½ÉÀº '¹ß°ßµÈ °©»ó¼± °áÀý'À» ¾î¶»°Ô ÇÒ °ÍÀΰ¡¶ó±âº¸´Ù´Â '¹ß°ßÇÒ Çʿ䰡 ÀÖÀ»±î?' Áï °ËÁøÀÇ Çʿ伺ÀÏÅÙµ¥¿ä...
* Âü°í: EndoTODAY °©»ó¼±¾Ï screeningÀÌ ÇÊ¿äÇѰ¡?
2. Statin and cancer - Ç÷¾×Á¾¾ç³»°ú °¿ø±â
Anticancer mechanism of statins
°¿ø±â ±³¼ö´ÔÀÇ °á·Ð ½½¶óÀ̵å
1) In preclinical studies, increasing evidence suggests that statins may enhance the antitumor activity of chemotherapeutic agents.
2) Numerous clinical protocols are currently under investigation combining statins with classic cytotoxic drugs, small molecule tyrosine kinase inhibitors as well as monoclonal antibodies, in order to test their ability to synergize the effect of traditional chemotherapy and to prevent or revert the development of resistance.
3) At present, there are no certain conclusions regarding the association between statin intake and cancer prevention and treatment.
3. À§½Äµµ¿ª·ùÁúȯ ÃÖ½ÅÁö°ß - ¼Òȱ⳻°ú ÀÌdz·Ä
°ÀÇ´Â µèÁö ¸øÇÏ°í °ÀǷϸ¸ º¸¾Ò½À´Ï´Ù.
ÀϺ»¿¡¼ ¹Ù·¿½Äµµ¿Í ¹Ù·¿½Äµµ¾ÏÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â ÀϺ» µ¥ÀÌŸÀÔ´Ï´Ù (Lee HS. Clin Endosc 2014).
[ÀÌÁØÇà Àǰß]
¹Ù·¿½Äµµ¿Í ¹Ù·¿½Äµµ¾Ï¿¡ ´ëÇÑ ÀϺ»ÀÇ Áø´ÜÀº ¸Å¿ì ƯÀÌÇÕ´Ï´Ù. »ç¼ÒÇÑ ÀÌ»óÀÌ Å©°Ô °Á¶µÇ´Â ºÐÀ§±âÀÔ´Ï´Ù. ÀϺ»¿¡¼ ¹Ù·¿½Äµµ¾ÏÀÌ ½ÇÁ¦·Î Áõ°¡Çϰí ÀÖ´ÂÁö Àú´Â È®½ÅÇÏÁö ¸øÇϰí ÀÖ½À´Ï´Ù.
°¢ ÆÄÆ®º° senior ¼±»ý´ÔµéÀÇ Á¤¼º½º·± °ÀǷΠä¿öÁø ¸ÚÁø ½ÉÆ÷Áö¾öÀ̾ú½À´Ï´Ù. ±×·±µ¥ ³»°ú Àü°øÀÇ ¼±»ý´Ôµé, ÀÓ»ó°»ç ¼±»ý´ÔµéÀÇ Âü¼®·üÀÌ ÀúÁ¶ÇØ ¾Æ½¬¿ü½À´Ï´Ù. ¿¹Àü °°À¸¸é ÀÌ·± Çà»ç¿¡´Â '°Á¦µ¿¿ø'ÀÌ °üÇàÀ̾ú½À´Ï´Ù. ÀÏ¿äÀÏÀ̰í ÇǰïÇÏÁö¸¸ ¾î¿ ¼ö ¾øÀÌ Çà»çÀå¿¡ ¾É¾Æ ÀÖ¾ú½À´Ï´Ù. ÀÚ´Ù±ú´Ù °ÀǸ¦ µé¾úÁö¸¸ ¹º°¡ ³²´Â °ÍÀº ÀÖ¾ú½À´Ï´Ù.
¿äÁòÀº °Á¦µ¿¿øÀÌ ºÒ°¡´ÉÇÕ´Ï´Ù. Àü°øÀÇ ¼±»ý´ÔµéÀÇ ÁÖ´ç ±Ù¹«½Ã°£À» º¸ÀåÇØÁÖ¾î¾ß Çϱ⠶§¹®ÀÔ´Ï´Ù. ½ÉÆ÷Áö¾ö¿¡ Âü¼®Çϵµ·Ï °ú Â÷¿ø¿¡¼ ±ÇÇÏ¸é ±× ¶ÇÇÑ ±Ù¹«½Ã°£À¸·Î °£Áֵ˴ϴÙ. ÇѸ¶µð·Î ºÒ¹ýÀÌ´Ï´Ù. °Á¦ÇÒ ¼ö ¾ø½À´Ï´Ù. ½º½º·Î ã¾Æ¿Í µè±â¸¦ ±âµµÇÒ »ÓÀε¥ ¹ø¹øÈ÷ ½Ç¸ÁÀÔ´Ï´Ù. ¾ÈŸ±õ½À´Ï´Ù.
°³ÀÎ ½Ã°£À» º¸È£ÇÏ´Â °ÍÀº ´ç¿¬ÇÑ ÀÏÀÔ´Ï´Ù. ±×·¯³ª ÀÌ·± Àú·± ÀÌÀ¯·Î ±³À°ÀÌ ºÎ½ÇÇØÁö´Â °ÍÀ» ÁöÄѺ¸´Â Á¦ ¸¶À½Àº ÆíÄ¡ ¾Ê¾Ò½À´Ï´Ù.
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.